Last year was a surprisingly big one for legal decisions impacting the biotechnology transactions and licensing space. Given ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

Environmental biotechnology is the branch of biotechnology that addresses environmental problems, such as the removal of pollution, renewable energy generation or biomass production, by exploiting ...

US lawmakers and industry leaders are intensifying calls for stricter export controls to prevent American biopharmaceutical ...

US lawmakers and industry leaders are calling for stricter export control regulations to prevent US biopharmaceutical companies from collaborating with China's military on biotechnology initiatives.

Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. In a surprising move on a lightning-quick ...

Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...

Continuously trying to find new ways of treating diabetes, cancer, and autoimmune diseases, the Indian biotech company has developed and commercialized novel biologics, biosimilars, and complex small ...

Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales, doubling from Q4 2023. Trading at 57x 2024 earnings, Krystal's stock appears expensive but is ...

From the heart of the English commuter town, UK biotech Autolus will process, manufacture and ship to the US a new Car-T cell therapy to treat the blood cancer acute lymphoblastic leukaemia (ALL ...